CI 21108 is classed chemically as a disazo colour.
製品には実際どれくらい入っているか
この成分の含有量を表示した製品はまだありません。
この成分を含む製品のうち3件は全成分の前の方（1%ラインより前）、0件は後ろ（ふつう1%以下）に書いています。
この成分を含む製品
確認済み 3件中 3件 · 十分に入っている製品から
定義
米国FDA 物質登録 · UNII 67HO7X7FV3 · 登録名 PIGMENT YELLOW 83 · 単一の化学物質
CI 21108 is classed chemically as a disazo colour. It conforms to the formula:
化粧品での役割
色をつけるCOLORANT
安全性・規制情報
- 制限
- 中国
出典: 韓国食薬処 化粧品規制情報
アルゼンチン · ブラジル
- Field of application and/or use : Dye Substances allowed exclusively in products that have short time of skin and hair contact.
- Other limitations and requirements : Maximum dimethylbenzidine concentration:
ASEAN
- Field of application : Colouring agents allowed exclusively in cosmetic products intended to come into contact only briefly with the skin.
- Other limitations and requirements : Maximum 3,3’-dimethylbenzidine concentration in the colouring agent: 5 ppm
台湾
- 2. 未列載於此表規定範圍之成分，於歐盟、美國及日本三國家地區，任何其中一個國家地區官方已公告（以生效日為準）其使用基準者，得參照其基準規定准予使用(但下表CI 11380 等十九項成分不適用)，惟於申請查驗登記時，應同時檢附該等地區之准許使用基準證明文件。
- 用途 : 色素
欧州連合
- Product Type, body parts : Rinse-off products
- Other : Maximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm
出典: 韓国食薬処 化粧品規制情報
韓国の有害物質GHS分類なし · 既存化学物質
EU化粧品規則 附属書IV（許可着色剤） 第48項 · 最大濃度 Rinse-off products
出典: EU 許可着色剤（附属書IV）
Restriction IV/48
出典: EU CosIng 成分リスト
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
CI 21108INCIButanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxo-別名
- CAS No.化学物質登録番号
- 5567-15-7
- EC No.EU化学物質目録番号
- 226-939-8
- DTXSID米国EPA化学物質番号
- DTXSID1021453
- DTXCID米国EPA化合物番号
- DTXCID90809908
- IUPAC
- 2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(diazene-2,1-diyl)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutanamide]
- 分子式
- C36H32Cl4N6O8
- 分子量
- 818.49 g/mol
測定された物性
- 性状
- Liquid, Wet Solid, Other Solid, Dry Powder, CBI · Yellow powder, [Trust Chem MSDS]
- 臭い
- 無臭
- 融点・凝固点
- &, gt, 320 ℃
- 比重
- 1.37 (20℃)
- n-オクタノール/水分配係数（Kow）
- 7.54
- 粘度
- (1.37g/㎤ at 20 ℃)
- 分子量
- 818.5
物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。
出典: PubChem · 韓国安全保健公団 SDS
製品が実際に使っている用途
米国EPAにこの成分を届け出た製品51件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。
- Pigment29
- Dye15
- Degradant/impurity (EPA)4
- Processing aids not otherwise specified3
出典: 米国EPA CompTox
刺激・感作試験の記録
皮膚試験8件・眼試験8件の記録があります。
低いと分類15件
試験の結論はおおむね一致しています（100%）。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。
試験16件をすべて見る
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: method given in the "Hazardous Substances Regulations" under the U.S. Federal Hazardous Substances Labelling Act Sect. 191.11 (February 1965) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: described in the "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" (1959) of the US Association of Food and Drug Officials (AFDO). according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: FDA-guidelines according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: described in the "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" (1959) of the US Association of Food and Drug Officials (AFDO) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: procedure set out in the "Hazardous Substances Regulations" under the U.S.A. Federal Hazardous Substances Labelling Act Sect. 191.12 (February 1965), conducted with slight modification. according to - Category 6.4A (Category 2A)
Eye Irritation · Read Across - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: FDA guideline (Fed. Reg., Vol. 37, No. 38, 1972) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: described in the "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" (1959) of the US Association of Food and Drug Officials (AFDO) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: FDA guideline (Fed. Reg. Vol. 37, No. 38, 1972) according to
出典: 米国EPA CompTox